Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K, Ishitsuka H
Department of Oncology, Nippon Roche Research Center, Kanagawa, Japan.
Cancer Chemother Pharmacol. 1993;32(5):333-8. doi: 10.1007/BF00735915.
The present study shows that various cytokines such as tumor necrosis factor (TNF alpha), interleukin-1 alpha (IL-1 alpha), and interferon-gamma (IFN gamma) make tumor cells much more susceptible to the cytostatic 5'-deoxy-5-fluorouridine (5'-dFUrd) than to 5-fluorouracil (5-FUra) and other cytostatics. These three cytokines increased the susceptibility of human cancer cell lines (COLO201, MKN45 and WiDr) but did not affect that of normal fibroblast WI38 cells. The cytokine mixture induced a 50-fold increase in the susceptibility of COLO201 to 5'-dFUrd, whereas a 12-fold increase and a less than 5-fold enhancement in the susceptibility to 5-FUra and other cytostatics, respectively, were observed. The increased susceptibility would be a result of the induction of thymidine phosphorylase (TdR Pase), which is the essential enzyme for the conversion of 5'-dFUrd to 5-FUra. The cytokine mixture increased TdR Pase activity by up to 47 times and greatly induced its mRNA expression in the cancer cell lines. These results suggest that the therapeutic benefit of 5'-dFUrd would be improved by its use in combination with the cytokines.
本研究表明,多种细胞因子,如肿瘤坏死因子(TNFα)、白细胞介素-1α(IL-1α)和干扰素-γ(IFNγ),使肿瘤细胞对细胞生长抑制剂5'-脱氧-5-氟尿苷(5'-dFUrd)的敏感性远高于对5-氟尿嘧啶(5-FUra)和其他细胞生长抑制剂的敏感性。这三种细胞因子增加了人类癌细胞系(COLO201、MKN45和WiDr)的敏感性,但对正常成纤维细胞WI38细胞的敏感性没有影响。细胞因子混合物使COLO201对5'-dFUrd的敏感性增加了50倍,而对5-FUra和其他细胞生长抑制剂的敏感性分别增加了12倍和不到5倍。敏感性增加是胸苷磷酸化酶(TdR Pase)诱导的结果,TdR Pase是将5'-dFUrd转化为5-FUra的关键酶。细胞因子混合物使TdR Pase活性提高了47倍,并在癌细胞系中极大地诱导了其mRNA表达。这些结果表明,5'-dFUrd与细胞因子联合使用可提高其治疗效果。